<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03839641</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 2018-029</org_study_id>
    <nct_id>NCT03839641</nct_id>
  </id_info>
  <brief_title>Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber</brief_title>
  <acronym>METFLEX</acronym>
  <official_title>Novel Approach to Assess Metabolic Flexibility in a Respiratory Chamber</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overarching aim of this study: To determine the effect of different meal compositions
      (high- vs. low-fat) on metabolic flexibility as it relates to meal-stimulated change in
      respiratory quotient (ΔRQ1) and sleep (ΔRQ2) metabolic flexibility, as well as the time
      course changes in respiratory quotient, RQ (i.e., peak RQ, time to peak RQ, nadir RQ, time to
      nadir, slope, area under the curve).
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 14, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in respiratory quotient</measure>
    <time_frame>12 hours</time_frame>
    <description>meal stimulated change in respiratory quotient</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>High Fat Meal First</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 1 participants randomized to receive high fat meal first, and low fat meal second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Fat Meal Second</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 2 participants randomized to receive low fat meal first, and high fat meal second</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High fat meal</intervention_name>
    <description>60% fat meal</description>
    <arm_group_label>High Fat Meal First</arm_group_label>
    <arm_group_label>High Fat Meal Second</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low fat meal</intervention_name>
    <description>20% fat meal</description>
    <arm_group_label>High Fat Meal First</arm_group_label>
    <arm_group_label>High Fat Meal Second</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eligibility criteria include:

               -  Healthy male or female

               -  Ages 18-40 y

               -  BMI between 20 kg/m2 and 30 kg/m2 (±0.5 kg/m2 will be accepted)

               -  Are willing to consume pre-prepared meals

               -  Are willing to maintain current physical activity, sleep schedule, and dietary
                  habits during the study.

               -  Medically cleared for participation in the study by Medical Investigator

        Exclusion Criteria:

          -  Participants are ineligible to participate (or will be excluded from participating in
             this study) if they meet any of the following criteria:

               -  Unstable weight in the last 3 months [gain or loss &gt;7 lb (or 3.2 kg)]

               -  Currently working shift work

               -  Smoking or use of tobacco products within the last 3 months

               -  Amenorrhea (or absence of regular monthly cycles)

               -  History of clinically diagnosed diabetes or a fasting blood glucose &gt;126 mg/dL

               -  Average screening blood pressure &gt;140/90 mmHg

               -  Previous bariatric surgery (or other surgeries) for obesity or weight loss

               -  Use of medications affecting metabolism or sleep

               -  History of neurological disease

               -  History of cardiovascular disease (or other chronic diseases)

               -  Pregnant, planning to become pregnant, or breastfeeding

               -  Adherence to special restrained diets (e.g., low-carbohydrate, low-fat, or
                  vegetarian/vegan diets) over the last 3 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808-4124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>February 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2019</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>David McDougal</investigator_full_name>
    <investigator_title>Assistant Professor-Research</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 29, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/41/NCT03839641/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

